Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CORNEAL DISORDER TREATMENT AGENT
Document Type and Number:
WIPO Patent Application WO/2024/042858
Kind Code:
A1
Abstract:
Provided is a novel agent or composition (agent or composition for treatment and/or prevention of a corneal disorder), etc. The agent or composition contains at least one glycosaminoglycan selected from among glycosaminoglycans having an average molecular weight of 10,000 or less and analogous substances (analogs, derivatives) thereto.

Inventors:
MITA SHIRO (JP)
Application Number:
PCT/JP2023/024223
Publication Date:
February 29, 2024
Filing Date:
June 29, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MS SCIENCE CORP (JP)
International Classes:
A61K31/726; A61K9/06; A61K9/08; A61K31/727; A61P27/02
Foreign References:
JP2011042632A2011-03-03
JPH10226704A1998-08-25
JP2006193521A2006-07-27
JPH04210922A1992-08-03
JP2007523912A2007-08-23
JP2020525416A2020-08-27
JP2004002369A2004-01-08
JP2013518127A2013-05-20
Other References:
TROCME, S.D.; HALLBERG, C.K.: "Heparin and Hyaluronate Prevent Major Basic Protein Inhibition of Corneal Epitherial Healing", PROCEEDINGS OF THE XVITH INTERNATIONAL CONGRESS OF ALLERGOLOGY AND CLINICAL IMMUNOLOGY, CANCÚN, OCTOBER 19 - 24, 1997, 1 January 1997 (1997-01-01) - 24 October 1997 (1997-10-24), Seattle, US, pages 386 - 389, XP009553230, ISBN: 0-88937-179-2
Attorney, Agent or Firm:
IWATANI Ryo (JP)
Download PDF: